相关实验视频

Updated: May 31, 2025

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

托法西提尼布聚焦:从传统配方到新型输送系统的迷人旅程

Priti Yadav¹, Sarika Wairkar¹

¹Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKMs NMIMS, V.L. Mehta Road, Vile Parle (W), Mumbai, Maharashtra 400056, India.

International journal of pharmaceutics

|January 22, 2025

概括

托法西提尼布通过抑制Janus激酶 (JAK) 途径有效治疗自身免疫性疾病. 新的输送系统正在开发中,以克服可溶性和降解性差等挑战,改善炎症状况的治疗结果.

科学领域:

药理学和药物输送药理学和药物输送
免疫学和炎症免疫学和炎症
纳米技术在医学中的应用

背景情况:

托法西提尼布是一种简氏激酶 (JAK) 抑制剂,用于治疗类风湿性关节炎等自身免疫性疾病.
它的有效性受到缺乏溶解性,透性和口腔降解的限制.
该JAK-STAT通路对于托法西提尼布向的炎症反应至关重要.

研究的目的:

审查目前和新兴的托法西提尼布输送配方.
分析托法西提尼布的物理化学,药理动力学和药理动力学特性.
探索先进的纳米载体系统,以改善药物输送.

主要方法:

对托法西提尼布配方和输送策略的文献综述.
对物理化学和药理动力学数据的分析.
探索纳米技术在药物输送中的应用.

主要成果:

在托法西提尼布的输送过程中发现了挑战:pH值依赖的溶解性,不良的透性,口服降解.
讨论了各种传递策略:口服修饰释放,局部/透皮,亲肠道.
突出纳米技术方法:脂质体,菌体,外体,纳米粒子.

结论:

先进的托法西提尼布输送系统可以克服目前的局限性.
纳米技术为增强托法西提尼布疗效和患者服药性提供了有前途的解决方案.
改进的输送策略将促进自身免疫和炎症疾病的治疗.

关键词:

自身免疫性疾病是一种自身免疫性疾病.有控制释放的释放.药物输送系统是药物输送系统.雅克抑制剂的使用纳米颗粒纳米颗粒托法西提尼布 (tofacitinib) 是一种可怕的药物.专题的交付专题的交付

更多相关视频

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on: October 15, 2017

相关概念视频

Drug Delivery: Miscellaneous Routes

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...

Drug Delivery: Overview

Drug Delivery: Overview

The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Drug Delivery: Enteral Route

Drug Delivery: Enteral Route

The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.

Drug Distribution: Tissue Binding

Drug Distribution: Tissue Binding

Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...